BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12580935)

  • 1. Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy.
    Terwee CB; Dekker FW; Bonsel GJ; Heisterkamp SH; Prummel MF; Baldeschi L; Wiersinga WM
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):192-8. PubMed ID: 12580935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
    Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
    Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
    Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Graves' ophthalmopathy: results of a European questionnaire study.
    Krassas GE; Segni M; Wiersinga WM
    Eur J Endocrinol; 2005 Oct; 153(4):515-21. PubMed ID: 16189172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighting of Facial Grading Variables to Disfigurement in Facial Palsy.
    Banks CA; Jowett N; Hadlock CR; Hadlock TA
    JAMA Facial Plast Surg; 2016 Jul; 18(4):292-8. PubMed ID: 27124886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
    Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments.
    Terwee CB; Dekker FW; Mourits MP; Gerding MN; Baldeschi L; Kalmann R; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):391-8. PubMed ID: 11298093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy.
    Wakelkamp IM; Gerding MN; van der Meer JW; Prummel MF; Wiersinga WM
    Clin Exp Immunol; 2002 Feb; 127(2):316-20. PubMed ID: 11876756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
    Batra R; Krishnasamy SK; Buch H; Sandramouli S
    Semin Ophthalmol; 2015 May; 30(3):227-31. PubMed ID: 24409943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of portwine stain disfigurement.
    Koster PH; Bossuyt PM; van der Horst CM; Gijsbers GH; van Gemert MJ
    Plast Reconstr Surg; 1998 Sep; 102(4):1210-6; discussion 1217-8. PubMed ID: 9734447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graves' ophthalmopathy].
    Badelon I; Morax S
    Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
    Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
    Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
    Choi SW; Lee JY; Lew H
    Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetic patients with Graves' disease have more frequent and severe Graves' orbitopathy.
    Le Moli R; Muscia V; Tumminia A; Frittitta L; Buscema M; Palermo F; Sciacca L; Squatrito S; Vigneri R
    Nutr Metab Cardiovasc Dis; 2015 May; 25(5):452-7. PubMed ID: 25746910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient- and observer-rated analysis of the impact of lateral rhinotomy on facial aesthetics.
    Lueg EA; Irish JC; Katz MR; Brown DH; Gullane PJ
    Arch Facial Plast Surg; 2001; 3(4):241-4. PubMed ID: 11710857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic orbital decompression for Graves' ophthalmopathy.
    Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
    Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Graves' ophthalmopathy in pregnancy.
    Stafford IP; Dildy GA; Miller JM
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1221-3. PubMed ID: 15863589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.